Yosemite — 2025 Investments
4 investments dated 2025 · listed companies and verified rows first · show all
Quarry Thera is a biotech developing oral small-molecule medicines based on induced-proximity pharmacology, using molecular glues and heterobifunctional compounds.
BiotechDeep TechNew Haven, US
Craig Crews(Co-Founder & Scientific Advisor)inDan McHugh(Manager)Tim Shannon(CEO and Board Member)inJeanne Magram(Chief Scientific Officer)inKanak Raina(Chief Technology Officer)Sean Cassidy(Chief Financial Officer)in
Co-investorsF-Prime CapitalCanaan PartnersLilly Ventures
Azalea Therapeutics develops precision genome editing therapies that engineer T cells directly inside the patient's body to create cancer immunotherapies, using proprietary delivery vehicles to target and modify specific genetic loci without ex vivo cell manipulation.
AI & Machine LearningBiotechMedical DevicesSan Francisco, US
Jennifer Doudna(Co-founder, Nobel Laureate in Chemistry and Li Ka Shing Chancellor's Chair in Biomedical and Health Sciences, UC Berkeley)Rodolphe Barrangou(Co-founder, Associate Professor of Medicine, UCSF)Krishnendu Roy(Co-founder, Professor of Bioengineering, Stanford University)Connor Tsuchida(Scientific Cofounder)in
Co-investorsThird Rock VenturesRA CapitalSozo Ventures
Daymark provides 24/7 in-home and virtual cancer care, offering patients an oncology-specialized team available by phone, text, video, or home visits to coordinate testing, manage symptoms and medications, and handle care logistics.
Digital HealthHealthtechMental HealthPhiladelphia, US
Justin Bekelman(Executive Officer, Director)inJonathan Rhodes(Founder)inPaul Dufault(Executive Officer)Roy Beveridge(Director)
BoardKelsey Maguire(Director)Ambar Bhattacharyya(Director)
Co-investorsBlue Venture FundsHealthier CapitalOncology VenturesMaverick Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.